About XRHealth
XRHealth combines immersive devices, digital therapies, mobile apps and remote clinical care for chronic physical, cognitive and behavioral conditions. AI analyzes home data and helps tailor therapy under licensed clinicians.
XRHealth has delivered more than one million therapy sessions, operates in 22 U.S. states and is involved in more than 50 clinical trials. Eran Orr is founder and chief executive officer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Oct 23, 2026 | $16,253,029fully sold | 2 | $8.1M | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 22, 2026 | Oct 23, 2026 | $3,877,693fully sold | 18 | $215K | EquityRule 506(b) | Form D ↗ |
| Feb 18, 2025 | Sep 16, 2026 | $22,849,963fully sold | 35 | $652K | EquityRule 506(b) | Form D ↗ |
| Feb 18, 2025 | Sep 16, 2026 | $2,300,000of $4.0M target | 5 | $460K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 8, 2026 | Sep 10, 2026 | $1,995,006fully sold | 3 | $665K | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $47,275,691 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by XRHealth
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Jan 9, 2024 | Funding | $6M | Asabys Partners (lead), NOVA Prime Fund and existing investors | Press release ↗ Asabys Partners ↗ |
| Feb 28, 2022 | Funding | $10M | HTC, Bridges Israel, AARP, StartEngine crowdfunding and existing investors | Press release ↗ |
| Apr 22, 2020 | Funding | $7M | Bridges Israel, Flint Capital and 20/20 HealthCare Partners (co-leads) | Press release ↗ |
Why Investors Backed XRHealth
Investors backed XRHealth because the company connects immersive medical devices, licensed clinical care and reimbursement in one platform. It has moved beyond VR into mobile digital therapies and wearables through acquisitions. XRHealth has delivered more than one million therapy sessions. Its clinical evidence and insurance pathways offer a route from experimental technology to routine home care.
The problem it targets
People with chronic conditions often receive separate care for pain, movement, mental health and other symptoms. XRHealth's view is that this leaves patients moving between specialists and treatments. Clinician supply also cannot keep pace with demand, especially when care depends on repeated in-person visits.
What the product does
Devices, apps and wearables collect information while patients use therapies at home. AI interprets that information and adapts treatment programs. Licensed clinicians monitor progress and change care plans. The platform covers physical rehabilitation, cognitive training, mental health, chronic pain and fibromyalgia.
Progress so far
XRHealth has delivered more than one million therapy sessions and is licensed in 22 U.S. states. It also has more than 50 active clinical trials and over 10 peer-reviewed publications. The Boston Globe reported that the company delivered one million user sessions in 2025 and had completed six acquisitions in two years.
Who backs it
Asabys Partners led XRHealth's $6 million funding in 2024. NOVA Prime Fund and existing investors also participated. Earlier funding came from HTC, Bridges Israel, AARP, Flint Capital, 20/20 HealthCare Partners and StartEngine investors.
How the market is moving
XRHealth bought Swing Therapeutics in July 2026, adding the FDA-authorized Stanza therapy and a virtual clinic for fibromyalgia and chronic pain. Medicare pays for some VR-based cognitive behavioral therapy as durable medical equipment. However, the Boston Globe reported that digital therapies still face slow adoption by clinicians and insurers.
We wrote this summary from public statements by XRHealth and its investors. It is not investment advice.
XRHealth in the News
- XRHealth prescribes augmented reality glasses for real-time telehealth
- Swing Therapeutics acquired by Needham-based medical VR platform XRHealth
- XRHealth acquires Innerworld to expand medical XR services
- XRHealth Leases 3,657 SF at 300 First Avenue in Needham, MA
- XRHealth acquires cognitive training VR company NeuroReality
Leadership Team
Executive officers and directors listed on XRHealth's Form D filed Oct 23, 2026.
